Heilongjiang ZBD Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.00%

Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Heilongjiang ZBD Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥406.37K

≈ $59.46K USD Cash + Short-term Investments

Total Assets

CN¥10.50 Billion

≈ $1.54 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 603567 asset base.

Liquid Assets Composition Over Time

This chart breaks down Heilongjiang ZBD Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Heilongjiang ZBD Pharmaceutical Co Ltd (603567) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥406.37K	0.0%
Total Liquid Assets	CN¥406.37K	0.00%

Asset Resilience Insights

Limited Liquidity: Heilongjiang ZBD Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Heilongjiang ZBD Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Heilongjiang ZBD Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Heilongjiang ZBD Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥438.51K ≈ $64.17K	CN¥10.63 Billion ≈ $1.56 Billion	0.00pp
2024-12-31	0.00%	CN¥537.23K ≈ $78.61K	CN¥12.71 Billion ≈ $1.86 Billion	+0.00pp
2023-12-31	0.00%	CN¥427.03K ≈ $62.49K	CN¥12.47 Billion ≈ $1.82 Billion	0.00pp
2022-12-31	0.00%	CN¥505.09K ≈ $73.91K	CN¥11.68 Billion ≈ $1.71 Billion	-6.16pp
2016-12-31	6.17%	CN¥396.00 Million ≈ $57.95 Million	CN¥6.42 Billion ≈ $939.30 Million	--

pp = percentage points

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$758.10 Million

CN¥5.18 Billion CNY

Market Cap Rank

#10305 Global

#2781 in China

Share Price

CN¥5.51

Change (1 day)

-0.90%

52-Week Range

CN¥4.28 - CN¥12.08

All Time High

CN¥28.17